4//SEC Filing
VIROPHARMA INC 4
Accession 0001127602-14-003250
CIK 0000946840operating
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 8:58 PM ET
Size
20.6 KB
Accession
0001127602-14-003250
Insider Transaction Report
Form 4
VIROPHARMA INCVPHM
Wolf John Peter III
VP, General Counsel
Transactions
- Disposition from Tender
Common Stock
2014-01-24$50.00/sh−110,768$5,538,400→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-24−27,265→ 0 totalExercise: $28.16From: 2013-01-05Exp: 2022-01-05→ Common Stock (27,265 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-24−32,516→ 0 totalExercise: $27.79From: 2014-06-10Exp: 2023-06-10→ Common Stock (32,516 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-24−34,570→ 0 totalExercise: $23.37From: 2014-01-03Exp: 2023-01-03→ Common Stock (34,570 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-24−20,131→ 0 totalExercise: $17.98From: 2012-06-06Exp: 2021-06-06→ Common Stock (20,131 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-24−26,793→ 0 totalExercise: $20.07From: 2013-06-04Exp: 2022-06-04→ Common Stock (26,793 underlying) - Award
Common Stock
2014-01-24+48,878→ 48,878 total - Disposition to Issuer
Common Stock
2014-01-24−48,878→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-24−18,059→ 0 totalExercise: $17.84From: 2012-01-05Exp: 2021-01-05→ Common Stock (18,059 underlying)
Footnotes (3)
- [F1]Performance-based awards entitling the reporting person to shares of VPHM common stock upon the satisfaction of certain criteria were deemed satisfied in connection with the merger of ViroPharma Incorporated with and into Shire Pharmaceutical Holdings Ireland Limited, effective as of January 24, 2014 and canceled in exchange for an amount equal to $50 per share.
- [F2]The options vest in four equal annual installments beginning on the anniversary date from time of grant.
- [F3]This derivative security, regardless of whether otherwise previously vested, was canceled in connection with the merger of ViroPharma Incorporated with and into Shire Pharmaceutical Holdings Ireland Limited, effective as of January 24, 2014 in exchange for a cash payment representing the difference between the per-share exercise price of the stock option and $50.
Documents
Issuer
VIROPHARMA INC
CIK 0000946840
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000946840
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 8:58 PM ET
- Size
- 20.6 KB